ClinicalTrials.gg
RecruitingNCT06387095Updated Apr 26, 2024

Efficacy of Parasternal Blocks in Cardiovascular Surgery Patients Undergoing Median Sternotomy

An interventional study of 1. no block and 2. superficial parasternal block in Postoperative Pain, sponsored by Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-04-26.

Sponsored by Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,107 studies in Pain, Postoperative with a site in Turkey — 266 open to participants now, 300 under way, none of them phase 3. Pain, Postoperative · Turkey.

Planned enrollment
5th of 892
300 · median 70
Started
2024
with 149 others
No phase
823 of 1,107
220 open now
Primary completion
2024-04
later than 11 of 299 live
Registered
491st of 1,107
by date

Among the 1,107 studies in Pain, Postoperative with a site in Turkey, this one is the 5th largest by planned enrollment of the 892 interventional ones that give a count, is one of 150 that started in 2024, is one of 823 with no phase, reaches primary completion later than 11 of the 299 other live ones, and was the 491st registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

266 of the 1,107 studies in Pain, Postoperative with a site in Turkey are open now. Recruiting first, the newest first:

261 more — sign in →

All 266 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,107 studies in Pain, Postoperative with a site in Turkey, or all of them as a file.
02

Study summary

Acute and chronic pain after cardiac surgery is a common problem that negatively affects quality of life. Postoperative pain after cardiac surgery is most intense in the first two days and decreases in the following period. However, postoperative pain with incomplete management in the acute period may become chronic. This may negatively affect the patient's quality of life. Although central blocks such as thoracic epidural and paravertebral blocks are considered the gold standard in analgesia control, the advantages of thoracic plan blocks, which are more superficial due to peroperative heparinisation; coagulation disorders; and procedural difficulties, are undeniable. Thoracic plane blocks, which can also be used in patients receiving anticoagulant and/or antiplatelet therapy, have recently been used for acute pain. The aim of this study was to evaluate the effect of thoracic plane blocks on extubation time, pain scores, intensive care unit (ICU) and hospital stays in patients undergoing median sternotomy.

Read the detailed description

The study will proceed in three arms. The first group is the control group and will receive total intravenous anaesthesia as infusion after peroperative induction until the patient leaves the operating room. The second group will receive ultrasound-guided parasternal superficial plan block after induction. The third group will receive ultrasound-guided parasternal deep plan block. Extubation times, additional analgesic needs, pain scores, intensive care unit duration and hospital discharge times will be compared in the three groups during intensive care unit follow-up. After extubation, patient-controlled analgesia will be applied for 24 hours (with pca infusion pump device).

03

Conditions studied

  • Postoperative Pain

Keywords

  • postoperative pain
  • parasternal blocks
  • chronic pain
  • acute pain
  • cabg
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Performing median sternotomy
  • Elective case
  • Over 18 years of age; under 80 years of age
  • patients

Exclusion criteria

Exclusion Criteria:

  • Emergency cases
  • Patients undergoing minimally invasive surgery
  • Patients with a history of opioid use in the last 30 days
  • Redo cases
  • Patients with less than 30%
  • Patients with severe hepatic or renal insufficiency
  • Patients with chronic pain before surgery (migraine, fibromyalgia)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Investigator)
Enrollment
300 participants (estimated)

Study arms

  • Active comparator
    1. control group

    control group. block will not be applied to this group and the patient's analgesia needs will be provided with patient-controlled analgesia devices.

    Procedure: 1. no block

  • Active comparator
    2. superficial parasternal plane block group

    superficial parasternal plane block group. superficial paraasternal plane block will be applied to this group. it will be applied to the parasternal region with ultrasound after the patient is intubated. patient-controlled analgesia devices will be used for additional postoperative pain needs.

    Procedure: 2. superficial parasternal block

  • Active comparator
    3. deep parasternal plane block group

    deep parasternal plane block group. deep paraasternal plane block will be applied to this group. it will be applied to the parasternal region with ultrasound after the patient is intubated. patient-controlled analgesia devices will be used for additional postoperative pain needs.

    Procedure: 3. deep parasternal block

Interventions

  • Procedure1. no block

    After extubation, patient-controlled analgesia will be applied for 24 hours (with PCA infusion pump device). During the follow-up of the patients in intensive care, extubation times, additional analgesic needs, pain scores; intensive care and hospital discharge times will be recorded.

    Also known as: intravenous analgesia

  • Procedure2. superficial parasternal block

    After induction, the patient will undergo an ultrasound-guided superficial parasternal plan block. . After extubation, patient-controlled analgesia will be applied for 24 hours (with PCA infusion pump device). During the follow-up of the patients in intensive care, extubation times, additional analgesic needs, pain scores; intensive care and hospital discharge times will be recorded.

    Also known as: intravenous analgesia, regional analjesia

  • Procedure3. deep parasternal block

    After induction, the patient will undergo an ultrasound-guided deep parasternal plane block. . After extubation, patient-controlled analgesia will be applied for 24 hours (with PCA infusion pump device). During the follow-up of the patients in intensive care, extubation times, additional analgesic needs, pain scores; intensive care and hospital discharge times will be recorded.

    Also known as: intravenous analgesia, regional analjesia

06

What researchers measure

Primary outcomes

  1. postoperative chronic pain

    Determination the effect of parasternal blocks on the incidence for chronic pain at 6 months postoperative period in cardiac surgery. The s-lanss scores of the patients at the 6th postoperative month will be evaluated. The range of the questionnaire is 0-24 and patients with a score above 12 will be considered to have neuropathic pain.

    Time frame: 6 months

Secondary outcomes

  1. postoperative 24 hours acute pain

    postoperative 24 hours pain of the patients will be evaluated with VAS (visual analogue scale). analgesic needs of the patients in the first 24 hours postoperatively will be calculated as morphine equivalent dose using PCA device. At the end of the 24th hour, BPI (brief pain index) will be evaluated. additional analgesic needs of the patients (NSAID, narcotic), if any, will be recorded. it will be evaluated whether there is a significant difference between the VAS scores, analgesic needs and BPI scores in the first 24 hours pain according to the groups.

    Time frame: 24 hours

  2. extubation time

    Extubation time (defined as the time from admission to intensive care unit until extubation) will be evaluated for differences between the groups.the control group

    Time frame: 24 hours

  3. icu time

    The study will look at whether intensive care and hospital discharge times differ between the groups.

    Time frame: 7 days

07

Study locations

1 of 1 sites recruiting
  • Kosuyolu High Education and Training Hospital
    Istanbul, Kartal, Turkey
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2024 to primary completion in Apr 2024, 2 months.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 2 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2024
First posted
Apr 26, 2024
StartActual
Feb 1, 2024
Primary completionActual
Apr 16, 2024
CompletionEst.
Aug 1, 2025
Last update
Apr 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06387095
Lead sponsor
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Responsible party
münire deniz (Principal Investigator Medical Doctor, Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital) — Principal investigator
First posted
Apr 26, 2024
Start date
Feb 1, 2024
Primary completion
Apr 16, 2024
Completion
Aug 1, 2025 (estimated)
Last update
Apr 26, 2024

Study contacts

omer savluk
Contact
dromersavluk@hotmail.com
+905056877440
munire deniz
study director · kosuyolu high education and training center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion